Center-Authored Papers

Filters: Author is Sakr, Wael A  [Clear All Filters]
2008
Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford DE.  2008.  Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.. Cancer. 112(10):2181-7. Abstract
2011
Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF et al..  2011.  Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917.. Cancer prevention research (Philadelphia, Pa.). 4(11):1761-9. Abstract
2013
Skinner EC, Goldman B, Sakr WA, Petrylak DP, Lenz H-J, Lee CT, Wilson SS, Benson M, Lerner SP, Tangen CM et al..  2013.  SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Non-Muscle Invasive Bladder Cancer Who Recurred Following at Least Two Prior Courses of Intravesical BCG.. The Journal of urology. Abstract